Datasets:

Suchinthana
/

support2-1

Dataset card Data Studio Files Files and versions Community

Split (1)

train · 9.11k rows

ID int64 1 9.11k	age float64 18 102	death int64 0 1	sex stringclasses 2 values	hospdead int64 0 1	slos int64 3 343	d.time int64 3 2.03k	dzgroup stringclasses 8 values	dzclass stringclasses 4 values	num.co int64 0 9	edu float64 0 31 ⌀	income stringclasses 4 values	scoma float64 0 100 ⌀	charges float64 1.17k 1.44M ⌀	totcst float64 0 633k ⌀	totmcst float64 -102.72 711k ⌀	avtisst float64 1 83 ⌀	race stringclasses 5 values	sps float64 0.2 99.2 ⌀	aps float64 0 143 ⌀	surv2m float64 0 0.97 ⌀	surv6m float64 0 0.95 ⌀	hday int64 1 148	diabetes int64 0 1	dementia int64 0 1	ca stringclasses 3 values	prg2m float64 0 1 ⌀	prg6m float64 0 1 ⌀	dnr stringclasses 3 values	dnrday float64 -88 285 ⌀	meanbp float64 0 195 ⌀	wblc float64 0 200 ⌀	hrt float64 0 300 ⌀	resp float64 0 90 ⌀	temp float64 31.7 41.7 ⌀	pafi float64 12 890 ⌀	alb float64 0.4 29 ⌀	bili float64 0.1 63 ⌀	crea float64 0.1 21.5 ⌀	sod float64 110 181 ⌀	ph float64 6.83 7.77 ⌀	glucose float64 0 1.09k ⌀	bun float64 1 300 ⌀	urine float64 0 9k ⌀	adlp float64 0 7 ⌀	adls float64 0 7 ⌀	sfdm2 stringclasses 5 values	adlsc float64 0 7.07
5,701	66.50195	1	male	0	3	380	Lung Cancer	Cancer	1	null	null	0	9,212	null	null	11	white	19.199219	20	0.658936	0.35498	1	0	0	metastatic	null	null	no dnr	3	88	9.599609	68	24	37.69531	null	null	null	1.5	142	null	97	15	null	null	null	null	2.089356
5,702	58.55399	0	male	0	40	408	CHF	COPD/CHF/Cirrhosis	2	8	$25-$50k	9	59,511	null	null	20.5	white	26.296875	43	0.782959	0.652954	1	0	0	no	0.85	0.75	no dnr	40	132	11.798828	125	28	35.29688	null	2.199707	0.199982	3.399902	129	null	237	38	null	null	0	null	0
5,703	56.879	1	female	0	19	26	ARF/MOSF w/Sepsis	ARF/MOSF	2	10	$11-$25k	26	28,747	null	null	14.333328	black	25.5	59	0.709961	0.622925	3	1	0	no	null	null	no dnr	19	65	13.199219	40	28	36	230	2.099609	0.899902	0.799927	147	7.509766	292	25	3,685	null	1	<2 mo. follow-up	1
5,704	68.70398	0	female	0	20	407	ARF/MOSF w/Sepsis	ARF/MOSF	1	14	null	41	67,965	null	null	27	white	34.195313	32	0.228973	0.129974	5	0	0	yes	0.7	0.5	no dnr	20	135	13.798828	115	40	36.79688	225	null	null	1	143	7.399414	154	17	4,350	null	0	no(M2 and SIP pres)	0
5,705	62.52698	1	male	0	11	36	ARF/MOSF w/Sepsis	ARF/MOSF	1	0	under $11k	9	47,565	null	null	15.5	black	17.796875	27	0.826904	0.767944	13	0	0	no	0.4	0.4	no dnr	11	128	23.296875	125	12	36.5	100	4	null	1.299805	132	7.419922	201	49	2,865	null	0	<2 mo. follow-up	0
5,706	38.116	0	male	0	33	407	Coma	Coma	0	null	$11-$25k	44	75,735	null	null	31.25	hispanic	19	29	0.803955	0.765991	1	0	0	no	null	null	no dnr	33	82	5.5	115	3	38.79688	255	2.699707	3.899902	0.799927	150	7.459961	98	10	4,680	null	0	adl>=4 (>=5 if sur)	0
5,707	55.60599	0	female	0	6	406	Colon Cancer	Cancer	1	null	null	0	19,455	null	null	16	white	18	34	0.820923	0.613892	1	0	0	metastatic	null	null	no dnr	6	80	20.597656	88	24	36.39844	null	3.699707	0.599976	0.699951	135	null	86	5	null	1	null	null	1.166748
5,708	32.75598	0	female	0	10	406	Colon Cancer	Cancer	1	12	under $11k	0	21,960	null	null	19.5	hispanic	21.199219	28	0.81897	0.609985	1	0	0	metastatic	0.85	0.65	no dnr	10	77	10.798828	80	16	38.09375	null	4.5	0.699951	0.799927	145	null	88	12	7,275	0	6	no(M2 and SIP pres)	6
5,709	58.51599	1	male	0	8	12	Lung Cancer	Cancer	2	16	>$50k	37	11,001	null	null	12.5	white	33	46	0.131989	0.007	1	0	0	metastatic	0.5	0.2	dnr after sadm	3	118	5.599609	115	24	35.59375	120.40625	3	0.5	0.799927	135	7.419922	91	10	2,020	null	6	<2 mo. follow-up	6
5,710	61.89999	0	male	0	46	405	ARF/MOSF w/Sepsis	ARF/MOSF	0	20	>$50k	0	154,913	null	null	31.25	white	22.597656	34	0.802979	0.737915	5	0	0	no	0.98	0.97	no dnr	46	102	7.099609	55	8	36.59375	205	2.199707	4.299805	0.599976	138	7.339844	246	19	1,090	null	0	adl>=4 (>=5 if sur)	0
5,711	30.467	0	male	0	123	405	CHF	COPD/CHF/Cirrhosis	2	14	$11-$25k	0	320,730	null	null	14.25	white	15.199219	19	0.953979	0.920898	1	0	0	no	null	null	no dnr	123	108	15.898438	110	22	36.79688	324	2.299805	1.299805	1.199951	140	7.40918	98	33	2,060	0	0	no(M2 and SIP pres)	0
5,712	55.806	0	male	0	12	404	ARF/MOSF w/Sepsis	ARF/MOSF	1	2	under $11k	0	15,359	null	null	14	black	21.199219	30	0.866943	0.819946	1	0	0	no	null	null	no dnr	12	73	5.199219	170	26	36.29688	null	null	2.599609	1.099854	140	null	95	15	2,160	1	2	no(M2 and SIP pres)	2
5,713	39.28799	1	male	1	4	4	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	under $11k	37	67,588	null	null	23	black	38.5	67	0.392944	0.274963	8	0	0	no	null	null	dnr after sadm	2	108	14.099609	115	8	38.09375	160	2.399902	1.399902	8.699219	139	7.40918	216	96	215	null	null	<2 mo. follow-up	2.919434
5,714	76.82397	0	female	0	29	404	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	0	130,680	null	null	23	white	27.296875	39	0.60791	0.500977	21	0	0	no	0.85	0.75	no dnr	29	72	16.699219	65	10	37.5	120	null	0.899902	1.299805	139	7.479492	151	27	940	null	1	adl>=4 (>=5 if sur)	1
5,715	68.75598	0	female	0	7	404	Colon Cancer	Cancer	1	14	$25-$50k	0	9,662	null	null	8	white	10.298828	10	0.884888	0.738892	1	0	0	metastatic	0.9	0.8	no dnr	7	95	11.599609	55	29	35.69531	108.32812	2.5	2.299805	2.899902	123	7.349609	109	72	1,290	0	0	no(M2 and SIP pres)	0
5,716	70.66095	0	male	0	37	404	MOSF w/Malig	ARF/MOSF	1	16	null	44	70,272	null	null	18.75	white	22.699219	38	0.533936	0.418945	1	0	0	yes	0.1	0.1	dnr after sadm	2	122	19.097656	135	10	35.89844	247.5	5.099609	5.099609	5.899414	148	7.389648	243	51	140	0	0	no(M2 and SIP pres)	0
5,717	37.76898	0	female	0	9	403	ARF/MOSF w/Sepsis	ARF/MOSF	3	8	under $11k	0	19,026	null	null	17	white	24.5	57	0.876953	0.832886	1	1	0	no	0.8	0.7	no dnr	9	107	9.898438	80	20	36	null	2.899902	0.599976	3.899902	132	null	73	56	4,025	6	null	no(M2 and SIP pres)	4.527344
5,718	22.905	0	male	0	20	403	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$11-$25k	0	79,249	null	null	26.333328	white	34.796875	69	0.747925	0.667969	7	0	0	no	0.9	0.9	no dnr	20	135	37.695313	135	10	38.89844	135.53125	2	1.299805	1.199951	134	7.429688	164	9	4,413	null	0	no(M2 and SIP pres)	0
5,719	72.73395	1	female	0	70	140	COPD	COPD/CHF/Cirrhosis	1	14	under $11k	26	186,634	null	null	31.5	black	18.699219	40	0.780884	0.648926	1	0	0	no	0.8	0.7	no dnr	70	122	24.597656	100	30	35.19531	436.625	null	0.599976	1.199951	144	7.369141	261	22	3,005	null	0	SIP>=30	0
5,720	72.80194	0	male	0	38	400	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$11-$25k	9	193,359	null	null	34.75	white	27	58	0.629883	0.526978	7	0	0	no	0.3	0.25	no dnr	38	111	8	69	24	36.59375	null	null	null	1	139	null	92	8	4,450	null	0	adl>=4 (>=5 if sur)	0
5,721	70.68896	1	male	1	13	13	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	null	0	95,812	null	null	40.5	white	26.199219	50	0.712891	0.625	4	0	0	no	0.3	0.25	no dnr	13	48	10.298828	175	38	38.29688	260	1.899902	null	10.898438	131	7.279297	89	68	0	null	0	<2 mo. follow-up	0
5,722	73.771	1	male	1	5	5	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	0	162,977	null	null	58	white	48.195313	107	0.074997	0.028	27	0	0	no	0.4	0.3	dnr after sadm	5	108	11.099609	75	34	39.59375	142.5	3.199707	null	0.899902	139	7.439453	146	24	3,140	null	null	<2 mo. follow-up	2.118652
5,723	67.77295	0	male	0	19	400	ARF/MOSF w/Sepsis	ARF/MOSF	2	11	$25-$50k	0	103,944	null	null	30.333328	white	22.796875	18	0.703979	0.61499	11	0	0	yes	0.8	0.75	no dnr	19	71	19.398438	72	36	35.79688	296.625	2.699707	0.699951	0.799927	137	7.439453	86	11	900	null	0	no(M2 and SIP pres)	0
5,724	72.97498	0	female	0	20	399	COPD	COPD/CHF/Cirrhosis	2	6	under $11k	44	59,837	null	null	23.666656	white	25.597656	50	0.566895	0.370972	1	1	0	no	0.2	0.25	dnr after sadm	3	124	17.796875	69	28	36	447	null	null	1.199951	136	7.509766	203	19	750	null	3	no(M2 and SIP pres)	3
5,725	53.01599	1	male	1	10	10	ARF/MOSF w/Sepsis	ARF/MOSF	1	11	under $11k	44	39,559	null	null	25	black	28.5	48	0.578979	0.468994	4	0	0	no	0.1	0.05	dnr after sadm	3	65	17.296875	52	29	35.5	396	null	41.59375	5.699219	143	7.189453	60	80	180	null	0	<2 mo. follow-up	0
5,726	66.92694	1	female	0	12	50	Colon Cancer	Cancer	1	11	null	0	12,287	null	null	8	white	27.898438	30	0.605957	0.28894	1	0	0	metastatic	0.8	0.1	no dnr	12	80	4	80	12	37.89844	null	4.299805	0.599976	0.799927	137	null	93	12	null	2	1	<2 mo. follow-up	1
5,727	64.05695	1	female	1	3	3	Coma	Coma	2	null	null	100	12,862	null	null	22	black	53.296875	89	0	0	1	1	0	no	0	0	no dnr	3	187	8.398438	55	40	38.69531	254.28125	null	null	0.799927	145	7.449219	123	13	1,930	null	null	<2 mo. follow-up	2.657715
5,728	66.30499	1	female	0	10	66	Colon Cancer	Cancer	2	2	under $11k	0	8,695	null	null	6	black	24	19	0.696899	0.407959	1	0	0	metastatic	0.9	0.5	no dnr	10	58	12.298828	80	30	39.29688	147.5	null	null	1.299805	144	7.269531	293	34	1,800	2	4	no(M2 and SIP pres)	4
5,729	77.06	1	male	0	12	49	CHF	COPD/CHF/Cirrhosis	2	12	under $11k	0	61,323	null	null	28.5	white	20.5	38	0.754883	0.612915	16	1	0	no	0.6	0.5	dnr after sadm	2	112	9.599609	105	30	37.59375	380.9375	3.299805	1.299805	0.5	137	7.439453	78	3	2,560	0	0	<2 mo. follow-up	0
5,730	73.93799	1	female	0	14	66	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	under $11k	0	32,261	null	null	22.333328	white	27.296875	52	0.716919	0.629883	1	0	0	no	0.6	0.5	no dnr	14	58	10.398438	135	22	38.29688	111.42188	null	0.599976	0.799927	136	7.379883	170	14	1,520	null	1	null	1
5,731	57.60999	1	female	1	42	42	MOSF w/Malig	ARF/MOSF	1	7	under $11k	0	160,066	null	null	28.5	black	23	43	0.69397	0.602905	3	1	0	yes	0.95	0.9	dnr after sadm	40	73	4.799805	100	36	36	214.8125	3.099609	0.399963	0.699951	125	7.419922	78	7	1,310	null	1	<2 mo. follow-up	1
5,732	63.74298	1	male	1	8	8	Cirrhosis	COPD/CHF/Cirrhosis	1	12	$25-$50k	0	9,053	null	null	11.5	white	30.398438	49	0.543945	0.345947	1	0	0	no	0.25	0.1	dnr after sadm	3	143	13	75	28	35.89844	280	2.5	0.599976	9.599609	131	7.379883	338	58	0	null	6	<2 mo. follow-up	6
5,733	68.94196	1	female	1	5	5	Coma	Coma	0	8	null	61	19,644	null	null	36	white	20	28	0.481995	0.409973	1	0	0	no	null	null	dnr after sadm	2	70	9.398438	80	30	35	null	2.899902	1.5	1	131	null	99	26	1,560	null	null	<2 mo. follow-up	1.856201
5,734	22.196	1	female	1	33	33	ARF/MOSF w/Sepsis	ARF/MOSF	0	16	under $11k	0	323,158	null	null	49.5	white	26.898438	63	0.853882	0.803955	10	0	0	no	0.4	0.4	dnr after sadm	33	83	7.599609	112	20	36.39844	null	null	null	0.5	138	null	105	5	null	null	0	<2 mo. follow-up	0
5,735	71.98395	1	female	1	7	7	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$11-$25k	41	94,706	null	null	39.5	white	44.195313	89	0.051994	0.016998	8	0	0	no	0.5	0.5	dnr after sadm	7	115	10.798828	125	38	38.39844	160	1.699951	4.199219	6.799805	136	7.429688	181	68	3,890	null	0	<2 mo. follow-up	0
5,736	65.58795	1	male	0	17	62	MOSF w/Malig	ARF/MOSF	2	11	$11-$25k	0	47,590	null	null	23.666656	white	23	25	0.716919	0.630981	1	1	0	yes	0.9	0.5	no dnr	17	58	10.5	125	36	36.79688	92.5	2.899902	1	1.599854	143	7.349609	95	36	2,365	0	0	null	0
5,737	46.18799	1	female	0	9	153	Coma	Coma	2	null	null	9	9,301	null	null	9.5	black	16.796875	16	0.797974	0.757935	1	0	0	metastatic	null	null	no dnr	9	127	13.898438	160	8	36.79688	165	2	1	4.699219	142	7.429688	164	76	4,200	null	null	null	2.668945
5,738	75.27997	1	female	0	6	158	COPD	COPD/CHF/Cirrhosis	2	12	$11-$25k	0	6,089	null	null	14	white	23.898438	13	0.75293	0.608887	1	0	0	no	0.8	0.3	dnr before sadm	0	77	12.798828	130	24	37.09375	323.75	null	0.399963	0.5	134	6.989258	97	15	null	3	1	no(M2 and SIP pres)	1
5,739	59.06897	0	female	0	7	391	COPD	COPD/CHF/Cirrhosis	1	12	$11-$25k	0	7,544	null	null	8.5	black	15.798828	16	0.918945	0.862915	1	0	0	no	0.9	0.9	no dnr	7	68	15.699219	115	10	35.69531	174.0625	null	2.699707	2.899902	145	7.469727	128	117	2,360	0	null	null	0.494751
5,740	40.91397	1	male	1	5	5	ARF/MOSF w/Sepsis	ARF/MOSF	0	10	under $11k	9	23,896	null	null	38	white	30.699219	66	0.75293	0.67395	2	0	0	no	0.7	0.7	dnr after sadm	3	52	23.898438	145	8	38.69531	200	1.5	0.599976	0.5	130	7.429688	109	6	2,645	null	6	<2 mo. follow-up	6
5,741	49.41498	1	male	1	6	6	MOSF w/Malig	ARF/MOSF	2	13	$25-$50k	0	32,612	null	null	44	white	31.398438	59	0.434998	0.315979	2	0	0	metastatic	0.1	0.05	dnr after sadm	6	55	16.898438	145	31	38.19531	162.5	2.799805	0.399963	1.099854	142	7.369141	117	32	527	null	0	<2 mo. follow-up	0
5,742	33.76297	0	male	0	14	389	ARF/MOSF w/Sepsis	ARF/MOSF	0	null	null	0	61,906	null	null	22.333328	white	23.796875	49	0.871948	0.827881	4	0	0	no	null	null	no dnr	14	74	1.899902	108	24	37.5	227.5	null	null	1	132	7.549805	93	10	null	null	null	null	2.276856
5,743	65.54999	1	male	1	47	47	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	0	319,757	null	null	34	white	38.5	52	0.273987	0.165985	32	0	0	yes	0.1	0	dnr after sadm	37	128	13.599609	125	10	36.09375	556	1.199951	1.699951	0.799927	134	7.259766	214	5	2,175	null	null	<2 mo. follow-up	2.163086
5,744	53.15799	1	female	1	20	20	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	0	108,762	null	null	42.666657	white	32.695313	33	0.67395	0.577881	3	0	0	no	0.4	0.35	no dnr	20	80	2.099609	60	20	36.5	null	4.299805	0.599976	1.099854	139	null	82	6	3,650	null	1	<2 mo. follow-up	1
5,745	73.39899	0	male	0	8	389	CHF	COPD/CHF/Cirrhosis	2	18	$11-$25k	0	12,499	null	null	17	white	17	24	0.868896	0.782959	1	0	0	no	0.9	0.8	no dnr	8	123	7.5	128	12	35.59375	null	3.699707	1	1.799805	145	null	199	36	450	1	1	no(M2 and SIP pres)	1
5,746	55.13797	1	female	1	5	5	Coma	Coma	2	14	$11-$25k	61	42,498	null	null	31	white	25.097656	23	0.402954	0.328979	5	0	0	no	0.1	0.1	dnr after sadm	5	40	12.898438	55	37	39.69531	303.3125	null	3	5.799805	136	7.379883	70	67	7	null	0	<2 mo. follow-up	0
5,747	74.935	0	male	0	14	388	ARF/MOSF w/Sepsis	ARF/MOSF	0	16	null	0	37,297	null	null	18.333328	white	26.398438	33	0.711914	0.623901	2	0	0	no	null	null	no dnr	14	109	4.099609	72	18	37.69531	null	3.699707	0.5	0.799927	136	null	92	4	2,550	null	0	no(M2 and SIP pres)	0
5,748	65.68097	1	male	1	13	13	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	$11-$25k	44	63,760	null	null	36.5	white	19.097656	45	0.74292	0.662964	2	1	0	no	0.5	0.45	dnr after sadm	13	100	62	100	24	37.59375	null	null	0.399963	0.799927	142	null	94	10	1,100	null	6	<2 mo. follow-up	6
5,749	66.185	1	male	1	3	3	ARF/MOSF w/Sepsis	ARF/MOSF	1	5	null	100	94,784	null	null	56	hispanic	43.898438	71	0.002	0	14	1	0	no	null	null	no dnr	3	75	16.796875	115	30	38.29688	140	null	1.599854	1.299805	137	7.519531	181	27	5,480	null	null	<2 mo. follow-up	3.267578
5,750	51.14297	0	male	0	6	386	Colon Cancer	Cancer	1	16	>$50k	0	11,328	null	null	11	white	9.599609	3	0.909912	0.790894	1	0	0	metastatic	null	null	no dnr	6	140	10.298828	105	26	36.29688	492	3.399902	null	8.398438	135	7.419922	282	48	390	0	0	no(M2 and SIP pres)	0
5,751	61.28998	1	male	1	11	11	ARF/MOSF w/Sepsis	ARF/MOSF	0	16	>$50k	0	40,815	null	null	23.5	white	30.296875	54	0.717896	0.630981	1	0	0	no	0.5	0.1	dnr after sadm	10	142	14.699219	115	33	35.69531	210	null	null	0.599976	123	7.439453	181	18	1,400	0	0	<2 mo. follow-up	0
5,752	33.32199	0	male	0	61	385	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	$11-$25k	44	null	null	null	37	black	20.898438	45	0.844971	0.790894	1	1	0	no	0.3	0.2	null	null	107	14.798828	60	14	36.79688	306.625	2.399902	0.699951	1.399902	142	7.40918	184	36	600	null	0	adl>=4 (>=5 if sur)	0
5,753	84.66498	0	male	0	11	384	ARF/MOSF w/Sepsis	ARF/MOSF	1	7	null	37	28,875	null	null	24.5	white	34.59375	43	0.201996	0.108994	1	0	0	yes	0.25	0.0156	no dnr	11	142	16	65	30	39	191.40625	null	null	1	140	7.469727	115	9	3,525	null	0	no(M2 and SIP pres)	0
5,754	62.06198	1	male	1	37	37	ARF/MOSF w/Sepsis	ARF/MOSF	1	14	$25-$50k	0	251,172	null	null	35	white	27.5	40	0.612915	0.507935	24	0	0	yes	0.6	0.5	dnr after sadm	30	57	6.299805	60	16	38	null	null	0.599976	0.699951	133	null	120	120	2,050	null	0	<2 mo. follow-up	0
5,755	47.48297	1	female	1	5	5	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$11-$25k	41	28,102	null	null	47	other	28	38	0.68396	0.589966	1	0	0	no	0.2	0.1	dnr after sadm	4	73	20.796875	125	16	38.59375	570	null	1.5	0.799927	137	7.289062	288	14	1,460	null	0	<2 mo. follow-up	0
5,756	44.79398	0	male	0	5	384	ARF/MOSF w/Sepsis	ARF/MOSF	0	11	>$50k	9	19,115	null	null	20	white	16	10	0.910889	0.878906	2	0	0	no	0.95	0.9	no dnr	5	108	10.398438	140	36	36.19531	null	2.699707	1.099854	1.5	143	null	134	53	null	null	0	no(M2 and SIP pres)	0
5,757	60.698	1	female	1	7	7	MOSF w/Malig	ARF/MOSF	1	14	$25-$50k	9	52,512	null	null	53.5	white	41.796875	70	0.115997	0.050995	1	0	0	metastatic	null	null	no dnr	7	102	7	120	24	38.69531	168.5625	2.199707	null	1.099854	150	7.469727	98	20	2,425	null	5	<2 mo. follow-up	5
5,758	75.49597	1	female	0	7	14	ARF/MOSF w/Sepsis	ARF/MOSF	3	null	null	37	9,065	null	null	7	white	16.199219	29	0.78894	0.719971	1	1	1	no	null	null	no dnr	7	78	8.398438	80	20	36.5	471.375	null	0.899902	1.299805	134	7.459961	77	23	1,850	null	5	<2 mo. follow-up	5
5,759	72.422	0	male	0	9	382	ARF/MOSF w/Sepsis	ARF/MOSF	1	4	$11-$25k	41	18,527	null	null	11.5	black	21.699219	27	0.689941	0.598999	1	0	0	no	0.25	0.25	dnr after sadm	1	117	17.097656	80	20	36.69531	376	null	0.5	6	139	7.369141	64	53	2,450	null	1	no(M2 and SIP pres)	1
5,760	85.01599	0	female	0	4	382	CHF	COPD/CHF/Cirrhosis	3	8	$11-$25k	0	3,918	null	null	4	white	13.898438	10	0.834961	0.730957	1	0	0	yes	0.75	0.65	no dnr	4	75	21.597656	125	44	34.79688	212.5	null	22.398438	0.899902	139	7.429688	76	9	395	null	null	no(M2 and SIP pres)	2.355469
5,761	76.00299	1	male	0	42	51	MOSF w/Malig	ARF/MOSF	1	15	>$50k	0	88,879	null	null	20.75	white	24.199219	48	0.585938	0.47699	2	0	0	metastatic	0.9	0.75	no dnr	42	75	13.798828	115	38	35.39844	338.0625	null	0.699951	0.699951	134	7.5	185	22	2,410	0	0	<2 mo. follow-up	0
5,762	58.24197	0	male	0	9	382	COPD	COPD/CHF/Cirrhosis	2	null	under $11k	0	31,389	null	null	29	white	27.699219	33	0.806885	0.687988	1	0	0	no	0.7	0.7	no dnr	9	117	7.5	72	20	36.79688	null	3.899902	0.5	0.699951	136	null	168	9	6,100	null	null	no(M2 and SIP pres)	2.666016
5,763	64.84094	1	male	0	4	28	Lung Cancer	Cancer	0	16	$11-$25k	0	4,582	null	null	6	white	5.399414	11	0.873901	0.715942	1	0	0	metastatic	0.7	0.5	no dnr	4	65	10.398438	115	29	38.59375	243.3125	null	1	1.799805	138	7.509766	117	24	4,410	null	2	<2 mo. follow-up	2
5,764	45.23199	1	male	0	55	369	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	$25-$50k	0	268,271	null	null	39	white	23.597656	51	0.850952	0.79895	3	1	0	no	0.9	0.9	no dnr	55	128	12.798828	115	12	36.09375	360	2.099609	0.199982	11.898438	138	7.399414	240	111	600	null	0	SIP>=30	0
5,765	78.836	1	female	0	6	370	COPD	COPD/CHF/Cirrhosis	1	12	under $11k	0	13,603	null	null	20	black	22.796875	42	0.745972	0.598999	1	0	0	no	0.8	0.8	no dnr	6	112	21.296875	125	40	38.39844	256	2.199707	10.599609	2.199707	132	7.459961	183	28	3,040	0	null	no(M2 and SIP pres)	0.494751
5,766	67.53497	0	female	0	21	381	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	null	0	70,783	null	null	27.333328	black	38.195313	44	0.442993	0.323975	3	0	0	no	0.5	0.4	no dnr	21	95	27.796875	125	38	37.59375	263.3125	4.199219	null	1	140	7.459961	192	28	1,065	null	0	no(M2 and SIP pres)	0
5,767	34.75699	0	male	0	17	380	ARF/MOSF w/Sepsis	ARF/MOSF	1	8	null	44	51,410	null	null	23.333328	black	18.398438	26	0.856934	0.807983	2	0	0	no	0.85	0.75	no dnr	17	58	13.199219	118	50	38.39844	206.65625	null	1.599854	1.199951	135	7.449219	351	37	3,605	null	0	no(M2 and SIP pres)	0
5,768	71.20599	0	male	0	6	379	COPD	COPD/CHF/Cirrhosis	2	12	under $11k	0	5,433	null	null	10	white	15.199219	18	0.855957	0.761963	1	0	0	yes	0.8	0.8	no dnr	6	58	10.199219	65	10	36.89844	190	null	null	2.599609	132	7.399414	160	81	4,690	0	5	no(M2 and SIP pres)	5
5,769	69.78796	0	female	0	7	379	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	under $11k	0	35,607	null	null	10	black	16.699219	10	0.846924	0.793945	7	0	0	no	0.9	0.9	no dnr	7	49	20.597656	200	12	37.69531	140	3	13.5	4.099609	151	7.279297	41	68	0	0	0	no(M2 and SIP pres)	0
5,770	51.33499	0	male	0	17	365	ARF/MOSF w/Sepsis	ARF/MOSF	2	13	under $11k	0	65,095	null	null	26.333328	white	26.5	37	0.773926	0.700928	1	0	0	yes	0.9	0.85	no dnr	17	68	11.798828	55	11	38.89844	165	null	null	0.699951	135	7.439453	149	17	3,270	null	0	no(M2 and SIP pres)	0
5,771	72.08197	0	female	0	4	363	COPD	COPD/CHF/Cirrhosis	1	8	$11-$25k	0	2,941	null	null	8	white	16.796875	7	0.865967	0.777954	1	0	0	no	0.8	0.8	no dnr	4	68	12.298828	125	36	36.39844	186.65625	3.399902	0.599976	1.099854	138	7.419922	331	24	565	3	0	no(M2 and SIP pres)	0
5,772	79.38397	1	male	1	4	4	MOSF w/Malig	ARF/MOSF	3	2	under $11k	0	17,612	null	null	48	black	42	71	0.186981	0.097992	1	0	0	yes	0.1	0.1	dnr after sadm	2	138	16.597656	195	35	41.09375	296.375	null	null	0.899902	131	7.449219	181	11	1,587	null	5	<2 mo. follow-up	5
5,773	73.71698	1	male	1	12	12	Lung Cancer	Cancer	2	11	$11-$25k	0	41,184	null	null	11.5	white	19.398438	2	0.633911	0.322998	1	0	0	metastatic	0.5	0.2	dnr after sadm	4	107	5.299805	80	20	36.69531	null	2.699707	1.5	2.299805	144	null	89	32	675	null	0	<2 mo. follow-up	0
5,774	73.81494	0	male	0	3	362	Lung Cancer	Cancer	1	12	$11-$25k	0	10,558	null	null	12	white	10.5	12	0.800903	0.576904	1	0	0	metastatic	0.9	0.6	no dnr	3	28	12	0	0	38.39844	306.625	3.899902	null	11.798828	153	7.40918	192	87	0	0	null	no(M2 and SIP pres)	0.494751
5,775	48.39999	0	female	0	43	361	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$25-$50k	0	91,974	null	null	19	white	32	73	0.711914	0.623901	3	0	0	no	0.9	0.9	no dnr	43	111	19.5	124	22	36.29688	null	null	null	0.599976	143	null	236	15	null	null	0	no(M2 and SIP pres)	0
5,776	80.29297	1	male	1	34	34	ARF/MOSF w/Sepsis	ARF/MOSF	0	13	$25-$50k	0	147,291	null	null	28.25	white	32.5	75	0.56189	0.449951	1	0	0	no	null	null	no dnr	34	65	7.599609	75	23	37.79688	203.3125	null	null	3	135	7.509766	131	112	4,060	null	0	<2 mo. follow-up	0
5,777	86.55194	0	female	0	6	360	ARF/MOSF w/Sepsis	ARF/MOSF	0	null	null	0	8,949	null	null	11	black	24.597656	33	0.710938	0.622925	1	0	0	no	0.9	0.85	no dnr	6	62	8.199219	120	42	36.79688	157.5	2.299805	1.399902	0.699951	150	7.469727	112	33	1,730	0	null	no(M2 and SIP pres)	0.494751
5,778	37.57999	0	female	0	15	360	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	0	52,072	null	null	24	white	23.199219	34	0.887939	0.848999	1	1	0	no	null	null	no dnr	15	65	28.898438	125	9	36.79688	205	2	null	1.299805	144	7.229492	104	31	1,165	null	0	null	0
5,779	56.38098	0	female	0	37	359	ARF/MOSF w/Sepsis	ARF/MOSF	1	15	under $11k	9	123,004	null	null	32.25	white	23.5	50	0.807983	0.743896	2	1	0	no	0.65	0.6	no dnr	37	73	12.5	148	24	36.19531	null	2.599609	6.099609	0.899902	129	null	172	31	465	null	6	no(M2 and SIP pres)	6
5,780	69.47595	0	female	0	17	358	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	under $11k	55	74,091	null	null	29.333328	black	22.398438	43	0.574951	0.463989	5	1	0	no	0.8	0.75	no dnr	17	132	8.699219	105	13	38.59375	230	null	null	0.5	137	7.539062	180	7	2,945	null	1	adl>=4 (>=5 if sur)	1
5,781	61.79599	1	male	1	15	15	ARF/MOSF w/Sepsis	ARF/MOSF	1	9	$11-$25k	41	66,966	null	null	36	white	33.296875	55	0.373962	0.255981	1	0	0	yes	0.4	0.4	no dnr	15	108	46.59375	140	12	38	356	1.199951	3	1.599854	130	7.299805	140	39	1,385	null	5	<2 mo. follow-up	5
5,782	75.92297	1	male	1	23	23	ARF/MOSF w/Sepsis	ARF/MOSF	2	11	$11-$25k	0	89,086	null	null	34.666657	white	25.796875	40	0.718994	0.632935	2	0	0	no	0.7	0.6	dnr after sadm	20	48	17.796875	170	33	38.59375	128	null	null	5	131	7.369141	110	111	235	null	0	<2 mo. follow-up	0
5,783	83.23297	1	female	1	3	3	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	null	41	16,502	null	null	29	white	74.5	64	0	0	5	0	1	yes	0	0	dnr after sadm	2	80	32.898438	70	6	39.39844	150	2.599609	0.899902	1.099854	131	7.479492	104	30	5,145	null	4	<2 mo. follow-up	4
5,784	71.31598	1	female	1	7	7	MOSF w/Malig	ARF/MOSF	1	12	null	26	28,355	null	null	21.5	white	33	64	0.16098	0.079987	7	0	0	metastatic	0.1	0	dnr after sadm	2	107	9.5	72	24	36.39844	null	3.799805	0.399963	0.5	141	null	210	3	1,975	null	1	<2 mo. follow-up	1
5,785	59.59198	0	male	0	20	355	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	null	0	83,944	null	null	19.666656	white	16	10	0.846924	0.794922	8	0	0	yes	null	null	no dnr	20	77	16.398438	66	22	36.19531	150	null	null	0.799927	133	7.449219	82	17	2,650	null	null	null	2.461426
5,786	42.49698	0	female	0	23	355	ARF/MOSF w/Sepsis	ARF/MOSF	0	10	under $11k	44	76,321	null	null	28	white	25.199219	30	0.75	0.670898	1	0	0	no	0.8	0.7	no dnr	23	80	18.398438	80	20	36.59375	314.25	null	null	1.199951	141	7.379883	109	33	1,925	null	0	no(M2 and SIP pres)	0
5,787	49.78	0	female	0	9	355	Colon Cancer	Cancer	1	14	null	9	22,099	null	null	21.5	white	29.699219	27	0.578979	0.257996	1	0	0	metastatic	0.9	0.75	no dnr	9	58	11.099609	115	26	35.29688	224	null	null	1.5	130	7.129883	290	110	990	0	null	no(M2 and SIP pres)	0.494751
5,788	66.11395	0	female	0	10	353	ARF/MOSF w/Sepsis	ARF/MOSF	0	13	$25-$50k	0	38,449	null	null	22	white	23.699219	26	0.793945	0.725952	2	0	0	no	0.9	0.88	no dnr	10	65	21.796875	125	22	36	148.875	2.399902	0.299988	2.399902	138	7.299805	195	89	950	0	0	no(M2 and SIP pres)	0
5,789	75.21997	1	male	1	8	8	Lung Cancer	Cancer	1	3	under $11k	9	17,272	null	null	33.5	black	21.597656	18	0.533936	0.210999	1	0	0	metastatic	0.5	0.2	no dnr	8	108	6.899414	115	32	38.5	304	1.799805	null	6.799805	142	7.379883	96	72	2,225	0	null	<2 mo. follow-up	0.494751
5,790	75.61395	0	female	0	7	354	CHF	COPD/CHF/Cirrhosis	3	null	null	0	14,778	null	null	12	black	23.199219	38	0.783936	0.653931	1	1	0	no	null	null	no dnr	7	85	19.898438	135	31	36.19531	132	null	4.899414	1.599854	130	7.359375	149	51	1,210	null	null	null	2.270996
5,791	87.71497	1	female	0	10	340	CHF	COPD/CHF/Cirrhosis	2	null	null	0	8,642	null	null	14	black	19.398438	28	0.790894	0.66394	1	0	0	no	null	null	dnr after sadm	2	45	13.199219	135	28	38.09375	220	null	null	0.899902	133	7.40918	144	11	3,160	null	null	null	3.406738
5,792	65.008	0	male	0	18	352	Lung Cancer	Cancer	1	12	$11-$25k	0	15,592	null	null	6.333332	white	16	17	0.726929	0.453979	1	0	0	metastatic	0.6	0.4	no dnr	18	68	null	78	26	36.59375	null	null	null	1.399902	134	null	97	30	2,590	0	0	no(M2 and SIP pres)	0
5,793	70.44495	1	male	1	39	39	ARF/MOSF w/Sepsis	ARF/MOSF	0	3	under $11k	44	171,822	null	null	33.75	white	21.097656	10	0.658936	0.560913	4	0	0	no	0.05	0.5	dnr after sadm	38	107	13.398438	65	25	35	276.625	null	null	0.599976	132	7.459961	170	13	1,550	null	0	<2 mo. follow-up	0
5,794	76.23499	0	male	0	13	351	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	under $11k	26	30,143	null	null	21	white	23.296875	17	0.67395	0.577881	2	0	0	no	0.75	0.75	no dnr	13	118	10.898438	55	12	35.89844	190	null	1.599854	1.599854	136	7.399414	154	29	7,560	null	1	no(M2 and SIP pres)	1
5,795	37.689	1	female	1	8	8	MOSF w/Malig	ARF/MOSF	1	12	$11-$25k	9	61,762	null	null	38	white	33.296875	70	0.358948	0.241974	13	0	0	yes	0.5	0.2	no dnr	8	68	12.898438	110	9	38.5	217.125	null	null	1.199951	142	7.329102	325	48	1,460	0	null	<2 mo. follow-up	0.494751
5,796	71.22198	1	male	1	13	13	ARF/MOSF w/Sepsis	ARF/MOSF	1	11	$11-$25k	0	109,881	null	null	40	white	25.5	49	0.694946	0.603882	10	1	0	no	0.5	0.4	dnr after sadm	13	42	18.699219	125	8	39.89844	166	null	null	3.699707	143	7.259766	122	77	15	null	0	<2 mo. follow-up	0
5,797	58.66699	1	male	0	59	196	ARF/MOSF w/Sepsis	ARF/MOSF	1	16	$25-$50k	0	130,457	null	null	23.75	white	19.5	11	0.845947	0.792969	1	0	0	yes	0.7	0.6	dnr after sadm	13	95	6.799805	68	20	37	null	3.899902	1	0.899902	138	null	98	6	5,060	null	7	adl>=4 (>=5 if sur)	7
5,798	56.91199	1	male	0	12	82	CHF	COPD/CHF/Cirrhosis	3	7	under $11k	0	13,279	null	null	10.5	white	21.699219	36	0.866943	0.779907	1	0	0	no	0.9	0.9	no dnr	12	72	29.097656	125	28	36.29688	192.5	2.5	3.5	1.699951	138	7.449219	123	74	1,645	6	null	no(M2 and SIP pres)	4.527344
5,799	33.59598	0	female	0	18	348	MOSF w/Malig	ARF/MOSF	1	12	$11-$25k	9	82,387	null	null	25.333328	white	34.898438	49	0.262939	0.156982	6	0	0	metastatic	null	null	no dnr	18	60	14.798828	60	10	38.19531	283.3125	2.599609	1.299805	9.099609	134	7.379883	249	39	0	null	0	no(M2 and SIP pres)	0
5,800	66.82495	0	male	0	3	348	Lung Cancer	Cancer	1	14	>$50k	0	8,769	null	null	6	white	16.699219	13	0.710938	0.428955	1	0	0	metastatic	null	null	no dnr	3	70	3	125	28	36.29688	125	2.699707	null	1.099854	132	7.539062	140	42	3,500	0	0	no(M2 and SIP pres)	0

Subsets and Splits

No community queries yet

The top public SQL queries from the community will appear here once available.